vs
Side-by-side financial comparison of Pediatrix Medical Group, Inc. (MD) and SCANSOURCE, INC. (SCSC). Click either name above to swap in a different company.
SCANSOURCE, INC. is the larger business by last-quarter revenue ($766.5M vs $493.8M, roughly 1.6× Pediatrix Medical Group, Inc.). Pediatrix Medical Group, Inc. runs the higher net margin — 6.8% vs 2.2%, a 4.7% gap on every dollar of revenue. On growth, SCANSOURCE, INC. posted the faster year-over-year revenue change (2.5% vs -1.7%). Over the past eight quarters, SCANSOURCE, INC.'s revenue compounded faster (0.9% CAGR vs -0.1%).
Pediatrix Medical Group, Inc. is a leading U.S. specialized medical service provider focusing on maternal-fetal care, neonatology, pediatric cardiology and other pediatric subspecialties. It partners with U.S. healthcare facilities to deliver evidence-based care to women, newborns and children.
ScanSource, Inc. is a leading global specialty technology distributor offering a broad portfolio of solutions including point-of-sale systems, barcode scanning tools, cybersecurity products, cloud services and communication solutions. It primarily serves value-added resellers, managed service providers and enterprise clients across North America, Latin America and Europe, covering retail, healthcare, industrial and public sector core segments.
MD vs SCSC — Head-to-Head
Income Statement — Q4 FY2025 vs Q2 FY2026
| Metric | | |
|---|---|---|
| Revenue | $493.8M | $766.5M |
| Net Profit | $33.7M | $16.5M |
| Gross Margin | — | 13.4% |
| Operating Margin | 9.9% | 2.3% |
| Net Margin | 6.8% | 2.2% |
| Revenue YoY | -1.7% | 2.5% |
| Net Profit YoY | 10.5% | -3.3% |
| EPS (diluted) | $0.40 | $0.75 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $493.8M | $766.5M | ||
| Q3 25 | $492.9M | $739.6M | ||
| Q2 25 | $468.8M | $812.9M | ||
| Q1 25 | $458.4M | $704.8M | ||
| Q4 24 | $502.4M | $747.5M | ||
| Q3 24 | $511.2M | $775.6M | ||
| Q2 24 | $504.3M | $746.1M | ||
| Q1 24 | $495.1M | $752.6M |
| Q4 25 | $33.7M | $16.5M | ||
| Q3 25 | $71.7M | $19.9M | ||
| Q2 25 | $39.3M | $20.1M | ||
| Q1 25 | $20.7M | $17.4M | ||
| Q4 24 | $30.5M | $17.1M | ||
| Q3 24 | $19.4M | $17.0M | ||
| Q2 24 | $-153.0M | $16.1M | ||
| Q1 24 | $4.0M | $12.8M |
| Q4 25 | — | 13.4% | ||
| Q3 25 | — | 14.5% | ||
| Q2 25 | — | 12.9% | ||
| Q1 25 | — | 14.2% | ||
| Q4 24 | — | 13.6% | ||
| Q3 24 | — | 13.1% | ||
| Q2 24 | — | 13.0% | ||
| Q1 24 | — | 12.6% |
| Q4 25 | 9.9% | 2.3% | ||
| Q3 25 | 13.8% | 3.5% | ||
| Q2 25 | 12.8% | 3.3% | ||
| Q1 25 | 7.0% | 3.2% | ||
| Q4 24 | 7.8% | 2.5% | ||
| Q3 24 | 6.6% | 2.3% | ||
| Q2 24 | -31.3% | 2.9% | ||
| Q1 24 | 3.2% | 2.3% |
| Q4 25 | 6.8% | 2.2% | ||
| Q3 25 | 14.5% | 2.7% | ||
| Q2 25 | 8.4% | 2.5% | ||
| Q1 25 | 4.5% | 2.5% | ||
| Q4 24 | 6.1% | 2.3% | ||
| Q3 24 | 3.8% | 2.2% | ||
| Q2 24 | -30.3% | 2.2% | ||
| Q1 24 | 0.8% | 1.7% |
| Q4 25 | $0.40 | $0.75 | ||
| Q3 25 | $0.84 | $0.89 | ||
| Q2 25 | $0.46 | $0.87 | ||
| Q1 25 | $0.24 | $0.74 | ||
| Q4 24 | $0.37 | $0.70 | ||
| Q3 24 | $0.23 | $0.69 | ||
| Q2 24 | $-1.84 | $0.66 | ||
| Q1 24 | $0.05 | $0.50 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $375.2M | $83.5M |
| Total DebtLower is stronger | $570.5M | — |
| Stockholders' EquityBook value | $865.9M | $910.9M |
| Total Assets | $2.2B | $1.7B |
| Debt / EquityLower = less leverage | 0.66× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $375.2M | $83.5M | ||
| Q3 25 | $340.1M | $124.9M | ||
| Q2 25 | $224.7M | $126.2M | ||
| Q1 25 | $99.0M | $146.3M | ||
| Q4 24 | $229.9M | $110.5M | ||
| Q3 24 | $103.8M | $145.0M | ||
| Q2 24 | $19.4M | $185.5M | ||
| Q1 24 | $8.0M | $159.1M |
| Q4 25 | $570.5M | — | ||
| Q3 25 | $577.2M | — | ||
| Q2 25 | $583.9M | — | ||
| Q1 25 | $590.5M | — | ||
| Q4 24 | $597.1M | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $865.9M | $910.9M | ||
| Q3 25 | $890.7M | $914.0M | ||
| Q2 25 | $833.8M | $906.4M | ||
| Q1 25 | $789.2M | $901.7M | ||
| Q4 24 | $764.9M | $900.7M | ||
| Q3 24 | $732.5M | $920.9M | ||
| Q2 24 | $706.5M | $924.3M | ||
| Q1 24 | $856.2M | $944.1M |
| Q4 25 | $2.2B | $1.7B | ||
| Q3 25 | $2.2B | $1.7B | ||
| Q2 25 | $2.1B | $1.8B | ||
| Q1 25 | $2.0B | $1.7B | ||
| Q4 24 | $2.2B | $1.7B | ||
| Q3 24 | $2.1B | $1.8B | ||
| Q2 24 | $2.0B | $1.8B | ||
| Q1 24 | $2.2B | $1.8B |
| Q4 25 | 0.66× | — | ||
| Q3 25 | 0.65× | — | ||
| Q2 25 | 0.70× | — | ||
| Q1 25 | 0.75× | — | ||
| Q4 24 | 0.78× | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $114.1M | $30.8M |
| Free Cash FlowOCF − Capex | — | $28.9M |
| FCF MarginFCF / Revenue | — | 3.8% |
| Capex IntensityCapex / Revenue | — | 0.3% |
| Cash ConversionOCF / Net Profit | 3.39× | 1.87× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $114.1M | $30.8M | ||
| Q3 25 | $137.3M | $23.2M | ||
| Q2 25 | $137.2M | — | ||
| Q1 25 | $-117.5M | $66.1M | ||
| Q4 24 | $133.0M | $-6.2M | ||
| Q3 24 | $91.8M | $44.8M | ||
| Q2 24 | $107.0M | — | ||
| Q1 24 | $-125.2M | $160.2M |
| Q4 25 | — | $28.9M | ||
| Q3 25 | — | $20.8M | ||
| Q2 25 | — | — | ||
| Q1 25 | — | $64.6M | ||
| Q4 24 | — | $-8.2M | ||
| Q3 24 | — | $42.5M | ||
| Q2 24 | — | — | ||
| Q1 24 | — | $157.7M |
| Q4 25 | — | 3.8% | ||
| Q3 25 | — | 2.8% | ||
| Q2 25 | — | — | ||
| Q1 25 | — | 9.2% | ||
| Q4 24 | — | -1.1% | ||
| Q3 24 | — | 5.5% | ||
| Q2 24 | — | — | ||
| Q1 24 | — | 21.0% |
| Q4 25 | — | 0.3% | ||
| Q3 25 | — | 0.3% | ||
| Q2 25 | — | 0.3% | ||
| Q1 25 | — | 0.2% | ||
| Q4 24 | — | 0.3% | ||
| Q3 24 | — | 0.3% | ||
| Q2 24 | — | 0.2% | ||
| Q1 24 | — | 0.3% |
| Q4 25 | 3.39× | 1.87× | ||
| Q3 25 | 1.91× | 1.17× | ||
| Q2 25 | 3.49× | — | ||
| Q1 25 | -5.66× | 3.79× | ||
| Q4 24 | 4.36× | -0.36× | ||
| Q3 24 | 4.72× | 2.64× | ||
| Q2 24 | — | — | ||
| Q1 24 | -31.03× | 12.51× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MD
| Health Care Patient Service | $421.6M | 85% |
| Hospitals Contracts | $70.0M | 14% |
| Other | $2.2M | 0% |
SCSC
| Products And Services | $723.4M | 94% |
| Intelisys Advisory | $25.0M | 3% |
| Recurring Revenue | $18.2M | 2% |
